首页 | 本学科首页   官方微博 | 高级检索  
检索        


Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients,Taiwan, July to August 2021
Institution:1. Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan;2. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan;3. Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan;4. Occupational Safety and Health Office, National Taiwan University Hospital, Taipei, Taiwan;5. Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan;6. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan;7. Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan;8. School of Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan
Abstract:
Keywords:Serologic response  Immunocompromised  Autoimmune disease  Non-steroidal anti-inflammatory drug  mRNA vaccine
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号